Trials / Conditions / DNA Damage Repair Deficiency
DNA Damage Repair Deficiency
4 registered clinical trials studyying DNA Damage Repair Deficiency — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Withdrawn | Breast/Cyclosporin A/TNBC (Triple Negative Breast Cancer) NCT06246786 | Virginia G. Kaklamani | EARLY_Phase 1 |
| Unknown | The Efficacy and Safety of Docetaxel Combined With Platinum for Metastatic Hormone-sensitive Prostate Cancer NCT05461261 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Phase 2 |
| Completed | Melatonin and DNA Damage Study NCT03945955 | University of British Columbia | Phase 4 |
| Recruiting | Olaparib With or Without Durvalumab for DDR Gene Mutated Biliary Tract Cancer Following Platinum-based Chemoth NCT05222971 | Asan Medical Center | Phase 2 |